(Q46702945)

English

A prospective cost-consequence analysis of adding lamivudine to zidovudine-containing antiretroviral treatment regimens for HIV infection in the US.

scientific article published in January 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10537440

A prospective cost-consequence analysis of adding lamivudine to zidovudine-containing antiretroviral treatment regimens for HIV infection in the US. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10537440

anti-retroviral agent

0 references

1 reference

based on heuristic

inferred from title

Richard C. Lindrooth

object named as

R Lindrooth

3

0 references

5

object named as

M Saag

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10537440

author name string

L Lacey

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10537440

J Mauskopf

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10537440

S Pham

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10537440

W Sawyer

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10537440

publication date

1 January 1999

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10537440

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10537440

15 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10537440

23-37

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10537440

https://scigraph.springernature.com/pub.10.2165/00019053-199915001-00003

0 references

Lamivudine reduces healthcare resource use when added to zidovudine-containing regimens in patients with HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the decision rules of cost-effectiveness analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Costs to Medicaid of advancing immunosuppression in an urban HIV-infected patient population in Maryland

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of antiviral treatment with zalcitabine plus zidovudine for AIDS patients with CD4+ counts less than 300/microliters in 5 European countries

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost-effectiveness of treatment with lamivudine and zidovudine compared with zidovudine alone: a comparison of Markov model and trial data estimates.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modelling the potential economic impact of viral load-driven triple drug combination antiretroviral therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modelling the Cost Effectiveness of Lamivudine/Zidovudine Combination Therapy in HIV Infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design of the Trial of Org 10172 in Acute Stroke Treatment (TOAST)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Confidence intervals for cost-effectiveness ratios: a comparison of four methods.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of cost-consequence analysis in healthcare decision-making

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Fédération National des Centres de Lutte contre le SIDA

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Zidovudine therapy and health resource utilization in AIDS

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination antiretroviral therapy in HIV infection. An economic perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Costs of HIV+/AIDS at CD4+ counts disease stages based on treatment protocols.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost Effectiveness of Low-Dose Zidovudine Therapy for Asymptomatic Patients with Human Immunodeficiency Virus (HIV) Infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/10537440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-199915001-00003

0 references

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10537440

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46702945&oldid=1584897503"